InnovaRx Innova Health Strategies

L85.1

Acquired keratosis [keratoderma] palmaris et plantaris

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 12 never code together
L85code
Excludes2
  • hypertrophic disorders of the skin (L91.-)L91.-
L85.1code
Excludes1
  • inherited keratosis palmaris et plantaris (Q82.8)Q82.8Q82.8
L00-L99chapter
Excludes2
  • certain conditions originating in the perinatal period (P04-P96)P04-P96
  • certain infectious and parasitic diseases (A00-B99)A00-B99
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
  • congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)Q00-Q99
  • endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
  • lipomelanotic reticulosis (I89.8)I89.8
  • neoplasms (C00-D49)C00-D49
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94
  • systemic connective tissue disorders (M30-M36)M30-M36
  • viral warts (B07.-)B07.-

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes

No further instructional notes apply.

Index entries leading here 4
  • Keratoderma, keratodermia (congenital) (palmaris et plantaris) (symmetrical) Q82.8
  • Keratosis L57.0
    • palmaris et plantaris (inherited) (symmetrical) Q82.8
  • Tylosis (acquired) L84
    • palmaris et plantaris (congenital) (inherited) Q82.8
  • Hyperkeratosis L85.9
    • palmoplantaris climacterica L85.1
Alongside this code 5 same parent — L85
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
L85
Block
L80-L99
Siblings
5

Present FY2024–FY2027.